Azithromycin targets the CD27 pathway to modulate CD27hi T-lymphocyte expansion and type-1 effector phenotype.
Saved in:
| Title: | Azithromycin targets the CD27 pathway to modulate CD27hi T-lymphocyte expansion and type-1 effector phenotype. |
|---|---|
| Authors: | Ansari AW; Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.; Dermatology Institute, Interim Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar., Jayakumar MN; Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates., Ahmad F; Dermatology Institute, Interim Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar., Venkatachalam T; Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates., Salameh L; Department of Pulmonary Medicine, Rashid Hospital, Dubai, United Arab Emirates., Unnikannan H; Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates., Raheed T; Dermatology Institute, Interim Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar., Mohammed AK; Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates., Mahboub B; Department of Pulmonary Medicine, Rashid Hospital, Dubai, United Arab Emirates., Al-Ramadi BK; Department of Medical Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.; Zayed Center for Health Sciences, United Arab Emirates University (UAEU), Al Ain, United Arab Emirates.; ASPIRE Precision Medicine Research Institute Abu Dhabi, United Arab Emirates University, Al Ain, United Arab Emirates., Hamid Q; Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.; Meakins-Christie Laboratories, Faculty of Medicine, McGill University, Montreal, QC, Canada., Steinhoff M; Dermatology Institute, Interim Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.; Department of Dermatology and Venereology, Hamad Medical Corporation, Doha, Qatar.; Weill Cornell Medicine-Qatar, Doha, Qatar.; College of Medicine, Qatar University, Doha, Qatar.; College of Health and Life Sciences, Hamad Bin Khalifa University, Doha, Qatar., Hamoudi R; Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.; Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.; Division of Surgery and Interventional Science, University College London, London, United Kingdom.; Biomedically Informed Artificial Intelligence Laboratory (BIMAI-Lab), University of Sharjah, Sharjah, United Arab Emirates.; ASPIRE Precision Medicine Research Institute Abu Dhabi, University of Sharjah, Sharjah, United Arab Emirates. |
| Source: | Frontiers in immunology [Front Immunol] 2024 Aug 15; Vol. 15, pp. 1447625. Date of Electronic Publication: 2024 Aug 15 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39211048 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Azithromycin targets the CD27 pathway to modulate CD27hi T-lymphocyte expansion and type-1 effector phenotype. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ansari+AW%22">Ansari AW</searchLink>; Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.; Dermatology Institute, Interim Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.<br /><searchLink fieldCode="AU" term="%22Jayakumar+MN%22">Jayakumar MN</searchLink>; Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Ahmad+F%22">Ahmad F</searchLink>; Dermatology Institute, Interim Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.<br /><searchLink fieldCode="AU" term="%22Venkatachalam+T%22">Venkatachalam T</searchLink>; Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Salameh+L%22">Salameh L</searchLink>; Department of Pulmonary Medicine, Rashid Hospital, Dubai, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Unnikannan+H%22">Unnikannan H</searchLink>; Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Raheed+T%22">Raheed T</searchLink>; Dermatology Institute, Interim Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.<br /><searchLink fieldCode="AU" term="%22Mohammed+AK%22">Mohammed AK</searchLink>; Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Mahboub+B%22">Mahboub B</searchLink>; Department of Pulmonary Medicine, Rashid Hospital, Dubai, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Al-Ramadi+BK%22">Al-Ramadi BK</searchLink>; Department of Medical Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.; Zayed Center for Health Sciences, United Arab Emirates University (UAEU), Al Ain, United Arab Emirates.; ASPIRE Precision Medicine Research Institute Abu Dhabi, United Arab Emirates University, Al Ain, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Hamid+Q%22">Hamid Q</searchLink>; Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.; Meakins-Christie Laboratories, Faculty of Medicine, McGill University, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Steinhoff+M%22">Steinhoff M</searchLink>; Dermatology Institute, Interim Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.; Department of Dermatology and Venereology, Hamad Medical Corporation, Doha, Qatar.; Weill Cornell Medicine-Qatar, Doha, Qatar.; College of Medicine, Qatar University, Doha, Qatar.; College of Health and Life Sciences, Hamad Bin Khalifa University, Doha, Qatar.<br /><searchLink fieldCode="AU" term="%22Hamoudi+R%22">Hamoudi R</searchLink>; Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.; Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.; Division of Surgery and Interventional Science, University College London, London, United Kingdom.; Biomedically Informed Artificial Intelligence Laboratory (BIMAI-Lab), University of Sharjah, Sharjah, United Arab Emirates.; ASPIRE Precision Medicine Research Institute Abu Dhabi, University of Sharjah, Sharjah, United Arab Emirates. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2024 Aug 15; Vol. 15, pp. 1447625. <i>Date of Electronic Publication: </i>2024 Aug 15 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39211048 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2024.1447625 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1447625 Titles: – TitleFull: Azithromycin targets the CD27 pathway to modulate CD27hi T-lymphocyte expansion and type-1 effector phenotype. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ansari AW – PersonEntity: Name: NameFull: Jayakumar MN – PersonEntity: Name: NameFull: Ahmad F – PersonEntity: Name: NameFull: Venkatachalam T – PersonEntity: Name: NameFull: Salameh L – PersonEntity: Name: NameFull: Unnikannan H – PersonEntity: Name: NameFull: Raheed T – PersonEntity: Name: NameFull: Mohammed AK – PersonEntity: Name: NameFull: Mahboub B – PersonEntity: Name: NameFull: Al-Ramadi BK – PersonEntity: Name: NameFull: Hamid Q – PersonEntity: Name: NameFull: Steinhoff M – PersonEntity: Name: NameFull: Hamoudi R IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 08 Text: 2024 Aug 15 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 15 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |